Editoria:Quinolones - A paradoxical adolescence. Lancet, II; 837 (1986).
2.
GraeffH., LoosW., HugoR., KrachklaK., FischbachF.: Ciprofloxacin in the treatment of patients with symptomatic and asymptomatic urinary tract infections: A comparative study of single dose application versus three days treatment concerning efficacy and safety. Abstracts 14th Intern. Congr. Chemoth., Kyoto; 50–59 (1985).
3.
MandellG. L., DouglasR. G.Jr., BebbettN. E.: Principles and practice of infectious diseases.Wiley Medical Publ., 1985.
4.
RahelJ. J., SimberkoffH. S.: Bacterial activity of ciprofloxacin against amikacin resistant from negative bacilli and methieillin resistant S. aureus. Abstracts 14th Intern. Congr. Chemoth., Kyoto, 33–42 (1985).
5.
SchalkhauserK., DalhoffA.: Clinical experience with Ciprofloxacine in the treatment of complicated urinary tract infections. Abstracts of the 14th Intern. Congr. Chemoth., Kyoto, 550–558 (1985).
6.
ScullyB. E., ParryM. F., NewH. C., MandellW.: Oral ciprofloxacine therapy of infections due to pseudomonas aeruginosa. Lancet, II; 819 (1986).